Sun Pharma withdraws suit filed by Ranbaxy against USFDA
The lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US.
Oct 09, 2015, 14:54 PM IST
Ranbaxy sues USFDA for revoking approval to sell 2 drugs
Ranbaxy Laboratories has sued USFDA over revoking an approval to sell generic versions of two drugs -- digestive disorder medicine Nexium and anti-viral Valcyte-- in the US market.
Nov 18, 2014, 20:00 PM IST
Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies
Ranbaxy Laboratories Ltd has sued the U.S. Food and Drug Administration (FDA) for revoking approvals granted to the firm to launch copies of two drugs including AstraZeneca Plc`s heartburn pill Nexium, court documents showed.
Nov 18, 2014, 15:35 PM IST
